A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy of CRx-102 in Subjects With Symptomatic Knee Osteoarthritis and Optional One-Year Extension

Trial Profile

A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy of CRx-102 in Subjects With Symptomatic Knee Osteoarthritis and Optional One-Year Extension

Discontinued
Phase of Trial: Phase II

Latest Information Update: 17 Jun 2014

At a glance

  • Drugs Dipyridamole/prednisolone (Primary) ; Prednisolone
  • Indications Osteoarthritis
  • Focus Therapeutic Use
  • Acronyms COMET-1
  • Sponsors Zalicus
  • Most Recent Events

    • 28 Apr 2014 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov record.
    • 22 Oct 2009 Results of the 12-month extension were announced at the American College of Rheumatology (ACR) 2009 Annual Meeting, according to CombinatoRx media release.
    • 13 Jun 2009 Resultswere reported at the 2009 EURLAR.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top